{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:15:11Z","timestamp":1790162111032,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jid.2020.03.972","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:15:58Z","timestamp":1588540558000},"page":"2455-2465.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1\/2 and ERK5 MAPK Pathways"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-4144","authenticated-orcid":false,"given":"Christian","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-5137","authenticated-orcid":false,"given":"Lorenza","family":"Fusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-6891","authenticated-orcid":false,"given":"Neele","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-4950","authenticated-orcid":false,"given":"Simon G.","family":"Goller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-4303","authenticated-orcid":false,"given":"Katharina","family":"Meder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-7961","authenticated-orcid":false,"given":"Verena G.","family":"Frings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-0357","authenticated-orcid":false,"given":"Hermann","family":"Kneitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7095-9848","authenticated-orcid":false,"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-2324","authenticated-orcid":false,"given":"Roland","family":"Houben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-8194","authenticated-orcid":false,"given":"David","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-1615","authenticated-orcid":false,"given":"Marc","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.03.972_bib1","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/0008-5472.CAN-18-2762","article-title":"Resistance to MAPK inhibitors in melanoma involves activation of the IGF1R-MEK5-Erk5 pathway","volume":"79","author":"Benito-Jard\u00f3n","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.03.972_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/onc.2012.88","article-title":"Oncogenic KRAS and BRAF activation of the MEK\/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4\/MKP2) resulting in nuclear ERK1\/2 inhibition","volume":"32","author":"Cagnol","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.972_bib3","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1182\/blood-2004-08-2985","article-title":"Multifunctional role of Erk5 in multiple myeloma","volume":"105","author":"Carvajal-Vergara","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2020.03.972_bib4","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1038\/ncomms11551","article-title":"ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1\/2 abrogation","volume":"7","author":"de Jong","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.03.972_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2020.03.972_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/MCB.22.1.270-285.2002","article-title":"Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2","volume":"22","author":"Espar\u00eds-Ogando","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2020.03.972_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/cdd.2008.193","article-title":"Regulation of neuronal survival by the extracellular signal-regulated protein kinase 5","volume":"16","author":"Finegan","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jid.2020.03.972_bib8","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.4049\/jimmunol.177.11.7607","article-title":"ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in\u00a0vivo","volume":"177","author":"Garaude","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.03.972_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-12-0386","article-title":"Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma","volume":"3","author":"Girotti","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.03.972_bib10","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1158\/0008-5472.CAN-04-4540","article-title":"Big mitogen-activated protein kinase 1\/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis","volume":"65","author":"Hayashi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.03.972_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI200419890","article-title":"Targeted deletion of BMK1\/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure","volume":"113","author":"Hayashi","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.03.972_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00109-004-0602-8","article-title":"Role of the BMK1\/ERK5 signaling pathway: lessons from knockout mice","volume":"82","author":"Hayashi","year":"2004","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jid.2020.03.972_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","article-title":"Oncogenic signaling of MEK5-ERK5","volume":"392","author":"Hoang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2020.03.972_bib14","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","article-title":"Mutation analysis of 24 known cancer genes in the NCI-60 cell line set","volume":"5","author":"Ikediobi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2020.03.972_bib15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1291\/hypres.30.1107","article-title":"Big mitogen-activated protein kinase 1 (BMK1)\/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration","volume":"30","author":"Izawa","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jid.2020.03.972_bib16","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.1093\/emboj\/16.23.7054","article-title":"BMK1\/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C","volume":"16","author":"Kato","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2020.03.972_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/27234","article-title":"Bmk1\/Erk5 is required for cell proliferation induced by epidermal growth factor","volume":"395","author":"Kato","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.03.972_bib18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cellsig.2010.01.020","article-title":"Erk 5 is necessary for sustained PDGF-induced Akt phosphorylation and inhibition of apoptosis","volume":"22","author":"Lennartsson","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.jid.2020.03.972_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15384101.2015.1120915","article-title":"Tumor cells with KRAS or BRAF mutations or ERK5\/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation","volume":"15","author":"Lochhead","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2020.03.972_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/BST20110663","article-title":"ERK5 and its role in tumour development","volume":"40","author":"Lochhead","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jid.2020.03.972_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2020.03.972_bib22","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1038\/sj.onc.1206839","article-title":"Activation of cyclin D1 expression by the ERK5 cascade","volume":"22","author":"Mulloy","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.972_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.03.972_bib24","doi-asserted-by":"crossref","first-page":"26199","DOI":"10.1074\/jbc.M110.103127","article-title":"Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)","volume":"285","author":"Ohnesorge","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.03.972_bib25","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1038\/s41388-018-0270-8","article-title":"A\u00a0kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis","volume":"37","author":"Pavan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.972_bib26","doi-asserted-by":"crossref","first-page":"34322","DOI":"10.18632\/oncotarget.9107","article-title":"MEK5\/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism","volume":"7","author":"Pereira","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.03.972_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.RES.0000112406.27800.6F","article-title":"Big mitogen-activated protein kinase (BMK1)\/ERK5 protects endothelial cells from apoptosis","volume":"94","author":"Pi","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jid.2020.03.972_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjc.6606062","article-title":"ERK5 signalling in prostate cancer promotes an invasive phenotype","volume":"104","author":"Ramsay","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2020.03.972_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jhep.2007.08.010","article-title":"ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells","volume":"48","author":"Rovida","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2020.03.972_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ncb1314","article-title":"The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene","volume":"7","author":"Rowland","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jid.2020.03.972_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2020.03.972_bib32","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Melanoma. Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2020.03.972_bib33","first-page":"1","article-title":"BRAFV600E mutations in malignant melanoma are associated with increased expressions of BAALC","volume":"7","author":"Schrama","year":"2008","journal-title":"J\u00a0Carcinog"},{"key":"10.1016\/j.jid.2020.03.972_bib34","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1128\/MCB.25.19.8553-8566.2005","article-title":"Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase","volume":"25","author":"Sohn","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2020.03.972_bib35","doi-asserted-by":"crossref","first-page":"46244","DOI":"10.1038\/srep46244","article-title":"Targeting BMK1 impairs the drug resistance to combined inhibition of BRAF and MEK1\/2 in melanoma","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2020.03.972_bib36","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2012.345","article-title":"MAP kinase signaling and inhibition in melanoma","volume":"32","author":"Sullivan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.972_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.03.972_bib38","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41388-018-0164-9","article-title":"ERK5 is activated by oncogenic BRAF and promotes melanoma growth","volume":"37","author":"Tusa","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.972_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejca.2017.06.028","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017","volume":"83","author":"Ugurel","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2020.03.972_bib40","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pone.0000236","article-title":"B-RAF and N-RAS mutations are preserved during short time in\u00a0vitro propagation and differentially impact prognosis","volume":"2","author":"Ugurel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2020.03.972_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2018.10.001","article-title":"KRAS suppression-induced degradation of MYC is antagonized by a MEK5-ERK5 compensatory mechanism","volume":"34","author":"Vaseva","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.03.972_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/MCB.25.1.336-345.2005","article-title":"Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5\/myocyte enhancer factor 2 cell survival pathway","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2020.03.972_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","article-title":"In\u00a0vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state","volume":"448","author":"Wernig","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.03.972_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ccr.2010.08.008","article-title":"Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein","volume":"18","author":"Yang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.03.972_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.stem.2014.04.015","article-title":"Klf2 is an essential factor\u00a0that sustains ground state pluripotency","volume":"14","author":"Yeo","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2020.03.972_bib46","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1074\/jbc.M109.056663","article-title":"FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms","volume":"285","author":"Czymai","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.03.972_bib47","doi-asserted-by":"crossref","first-page":"26199","DOI":"10.1074\/jbc.M110.103127","article-title":"Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)","volume":"285","author":"Ohnesorge","year":"2010","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2031407X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2031407X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:18:39Z","timestamp":1758302319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2031407X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022202X2031407X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.972","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1\/2 and ERK5 MAPK Pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}